Results for tag: "Everolimus"

Everolimus is a drug used in the treatment of breast cancer. It is an mTOR inhibitor, which works by blocking the activity of a protein that helps cancer cells grow and divide. It is used in combination with other drugs to treat advanced or metastatic breast cancer. Everolimus is also used to treat hormone receptor-positive, HER2-negative breast cancer that has spread to other parts of the body. It is typically used in combination with other drugs, such as letrozole or fulvestrant. Everolimus is available in tablet form and is taken orally. It is usually taken once daily, with or without food. Common side effects of Everolimus include nausea, vomiting, diarrhea, fatigue, and mouth sores. In the Everolimus market, some of the major players include Novartis, Pfizer, AstraZeneca, and Merck. Other companies involved in the market include Amgen, Teva Pharmaceuticals, and Eli Lilly. Show Less Read more